Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

823 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of diagnostic performance of word-list and story recall tests for biomarker-determined Alzheimer's disease.
Bruno D, Jauregi Zinkunegi A, Kollmorgen G, Carboni M, Wild N, Carlsson C, Bendlin B, Okonkwo O, Chin N, Hermann BP, Asthana S, Blennow K, Langhough R, Johnson SC, Pomara N, Zetterberg H, Mueller KD. Bruno D, et al. Among authors: carlsson c. J Clin Exp Neuropsychol. 2023 Oct;45(8):763-769. doi: 10.1080/13803395.2023.2240060. Epub 2023 Aug 12. J Clin Exp Neuropsychol. 2023. PMID: 37571873 Free PMC article.
Effect of Pathway-specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals.
Xu Y, Vasiljevic E, Deming YK, Jonaitis EM, Koscik RL, Van Hulle CA, Lu Q, Carboni M, Kollmorgen G, Wild N, Carlsson CM, Johnson SC, Zetterberg H, Blennow K, Engelman CD. Xu Y, et al. Among authors: carlsson cm. medRxiv [Preprint]. 2023 Feb 1:2023.01.30.23285142. doi: 10.1101/2023.01.30.23285142. medRxiv. 2023. Update in: J Alzheimers Dis. 2023;94(4):1587-1605. doi: 10.3233/JAD-230097 PMID: 36778431 Free PMC article. Updated. Preprint.
Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis.
Bocancea DI, Svenningsson AL, van Loenhoud AC, Groot C, Barkhof F, Strandberg O, Smith R; Alzheimer’s Disease Neuroimaging Initiative; La Joie R, Rosen HJ, Pontecorvo MJ, Rabinovici GD, van der Flier WM, Hansson O, Ossenkoppele R. Bocancea DI, et al. Brain. 2023 Sep 1;146(9):3719-3734. doi: 10.1093/brain/awad100. Brain. 2023. PMID: 36967222 Free PMC article.
Diagnostic accuracy of the plasma ALZpath pTau217 immunoassay to identify Alzheimer's disease pathology.
Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonatis E, Langhough RE, Cody K, Wilson R, Carlsson CM, Vanmechelen E, Montoliu-Gaya L, Lantero-Rodriguez J, Rahmouni N, Tissot C, Stevenson J, Servaes S, Therriault J, Pascoal T, Lleó A, Alcolea D, Fortea J, Rosa-Neto P, Johnson S, Jeromin A, Blennow K, Zetterberg H. Ashton NJ, et al. Among authors: carlsson cm. medRxiv [Preprint]. 2023 Jul 12:2023.07.11.23292493. doi: 10.1101/2023.07.11.23292493. medRxiv. 2023. PMID: 37502842 Free PMC article. Preprint.
Prevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease.
Erickson P, Simrén J, Brum WS, Ennis GE, Kollmorgen G, Suridjan I, Langhough R, Jonaitis EM, Van Hulle CA, Betthauser TJ, Carlsson CM, Asthana S, Ashton NJ, Johnson SC, Shaw LM, Blennow K, Andreasson U, Bendlin BB, Zetterberg H; ADNI Cohort. Erickson P, et al. Among authors: carlsson cm. JAMA Neurol. 2023 Jul 31;80(9):969-79. doi: 10.1001/jamaneurol.2023.2338. Online ahead of print. JAMA Neurol. 2023. PMID: 37523162 Free PMC article.
Glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer's disease: an exploratory study of 18F-FDG-PET.
Zhang Q, Fan C, Wang L, Li T, Wang M, Han Y, Jiang J; Alzheimer’s Disease Neuroimaging Initiative. Zhang Q, et al. Geroscience. 2024 Feb;46(1):1407-1420. doi: 10.1007/s11357-023-00897-0. Epub 2023 Aug 23. Geroscience. 2024. PMID: 37610594 Free PMC article.
CSF metabolites associated with biomarkers of Alzheimer's disease pathology.
Dong R, Lu Q, Kang H, Suridjan I, Kollmorgen G, Wild N, Deming Y, Van Hulle CA, Anderson RM, Zetterberg H, Blennow K, Carlsson CM, Asthana S, Johnson SC, Engelman CD. Dong R, et al. Among authors: carlsson cm. Front Aging Neurosci. 2023 Aug 30;15:1214932. doi: 10.3389/fnagi.2023.1214932. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37719875 Free PMC article.
Plasma Aβ42/40 and cognitive variability are associated with cognitive function in Black Americans: Findings from the AA-FAIM cohort.
Fischer B, Van Hulle CA, Langhough R, Norton D, Zuelsdorff M, Gooding DC, Wyman MF, Johnson A, Lambrou N, James T, Bouges S, Carter FP, Salazar H, Kirmess K, Holubasch M, Meyer M, Venkatesh V, West T, Verghese P, Yarasheski K, Carlsson CM, Johnson SC, Asthana S, Gleason CE. Fischer B, et al. Among authors: carlsson cm. Alzheimers Dement (N Y). 2023 Sep 25;9(3):e12414. doi: 10.1002/trc2.12414. eCollection 2023 Jul-Sep. Alzheimers Dement (N Y). 2023. PMID: 37752907 Free PMC article.
Gut Microbiome Compositional and Functional Features Associate with Alzheimer's Disease Pathology.
Kang JW, Khatib LA, Heston MB, Dilmore AH, Labus JS, Deming Y, Schimmel L, Blach C, McDonald D, Gonzalez A, Bryant M, Sanders K, Schwartz A, Ulland TK, Johnson SC, Asthana S, Carlsson CM, Chin NA, Blennow K, Zetterberg H, Rey FE; Alzheimer Gut Microbiome Project Consortium; Kaddurah-Daouk R, Knight R, Bendlin BB. Kang JW, et al. Among authors: carlsson cm. medRxiv [Preprint]. 2024 Sep 5:2024.09.04.24313004. doi: 10.1101/2024.09.04.24313004. medRxiv. 2024. PMID: 39281749 Free PMC article. Preprint.
823 results